Brief: Fulcrum Therapeutics Q1 Basic EPS USD -0.28
01/05/2025 12:00
May 01 (Reuters) - Fulcrum Therapeutics Q1 operating expenses USD 20.403 million. Q1 operating income USD -20.403 million Q1 net income USD -17.655 million
Recent news on Fulcrum Therapeutics
See all newsFulcrum Therapeutics, Inc. expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
U.S. STOCKS ON THE MOVE - KBR, Vista Energy, Fulcrum Therapeutics
Fulcrum to merge with Slate in all-stock deal after drug setback